Patients don’t know how to best manage their cholesterol

Patients don’t know how to best manage their cholesterol

Most people with high cholesterol are not sure how to manage the potentially deadly condition, according to a survey from the American Heart Association.

Nearly one in three American adults has high levels of LDL cholesterol, according to AHA statistics. It’s a serious health risk, because too much LDL — or “bad” — cholesterol can result in narrowed arteries and cause clots that can lead to a heart attack or stroke.

The survey was conducted as part of the AHA’s Check. Change. Control. Cholesterol initiative. Participants included nearly 800 people with a history of heart disease or at least one major risk factor, such as high blood pressure, high cholesterol or diabetes.

(Reuters) - Billionaire investor William Ackman said on Wednesday that his hedge fund had taken a roughly $1 billion stake in Lowe's , boosting the U.S. home improvement retailer's stock by 10.4 percent.

SINGAPORE/BEIJING (Reuters) - China will import record volumes of U.S. oil and is likely to ship more U.S. soy after Beijing signalled to state-run refiners and grains purchasers they should buy more to help ease tensions between the two top economies, trade sources said on Wednesday.

(Reuters) - Comcast Corp confirmed on Wednesday it was preparing a higher, all-cash offer for most of the media assets of Twenty-First Century Fox , setting up a bidding war with rival Walt Disney Co , which already has agreed to a $52-billion deal with Fox.

CHICAGO (Reuters) - U.S. health authorities said on Wednesday they were preparing to send an experimental Ebola treatment to the Democratic Republic of Congo for use in a clinical trial aimed at stemming an outbreak in the country that has spread to Mbandaka, a city of about 1.5 million people.

MBANDAKA, Democratic Republic of Congo (Reuters) - Three patients infected with the Ebola virus slipped out of an isolation ward at a hospital in the Congolese city of Mbandaka, health officials said, as medics raced to stop the deadly disease from spreading in the busy river port.

(Reuters) - Merck & Co said on Wednesday its drug Keytruda helped patients with a certain type of lung cancer live longer and prevented the disease from spreading, helping to solidify its position in the lucrative cancer market.